ORCL
Wall Street’s putting on the pom-poms
Oracle is set to report fourth-quarter earnings after the bell on Wednesday, June 10th, and analysts are busy doing what they do best: adjusting the scoreboard before the game starts.
The setup is pretty simple. Oracle’s shares slipped 2.8% on Tuesday to $205.81, but that hasn’t scared off the bulls. In the last few days alone, several firms nudged their outlooks higher:
- B of A Securities kept a Buy rating and lifted its target from $200 to $240.
- Evercore ISI stayed at Outperform and raised its target from $220 to $245.
- Oppenheimer stuck with Outperform and bumped its target from $235 to $275.
- TD Cowen kept a Buy rating and hiked its target from $250 to $300.
- Cantor Fitzgerald held Overweight and moved its target from $229 to $284.
Why you should care
This isn’t just Wall Street doing its usual confetti cannon routine. Oracle is one of the market’s louder cloud-and-AI names, and when analysts keep lifting targets right before earnings, it usually means they’re expecting a pretty healthy update on growth, backlog, or both.
The stakes are higher than your average earnings print, too. Oracle has beaten revenue estimates in only three of the last 10 quarters, so the bar isn’t exactly resting on the floor. Investors will be watching whether the company can back up the optimism with numbers that don’t just sparkle in a PowerPoint deck.
The bigger test
Consensus calls for Oracle to post $1.96 in quarterly EPS on $19.09 billion in revenue, both up from a year ago. That’s not tiny. But after a run of analyst upgrades, the market is basically asking one thing: is Oracle actually accelerating, or is this just Wall Street getting a little carried away with the cloud glow-up?
Big picture: if Oracle surprises to the upside, all this analyst enthusiasm can look genius. If it misses, those fresh price targets might start looking like they were drawn with a crayon.